- Nachrichtendetail
-
16.05.2024 13:48:21 - dpa-AFX: *LILLY : PHASE 3 TRIALS OF ONCE-WEEKLY INSULIN IN TYPE 2 DIABETES MEETS PRIMARY ENDPOINT
Copyright(c) 2024 RTTNews.com. All Rights Reserved
Copyright RTT News/dpa-AFX
Copyright RTT News/dpa-AFX
| Name | WKN | Börse | Kurs | Datum/Zeit | Diff. | Diff. % | Geld | Brief | Erster | Schluss | |
|---|---|---|---|---|---|---|---|---|---|---|---|
 |
ELI LILLY | 858560 | Xetra | 758,900 | 03.06.24 10:07:54 | +4,700 | +0,62% | 758,800 | 759,700 | 759,400 | 754,200 |
